ArticlePLoS medicine2014
Managing incidental genomic findings in clinical trials: fulfillment of the principle of justice.
Article in PLoS medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Practices and Attitudes toward Returning Genomic Research Results to Low-Resource Research Participants.Public health genomics · 2021Article
- Exploring neurologists' perspectives on the return of next generation sequencing results to their patients: a needed step in the development of guidelines.BMC medical ethics · 2018Article
- Practices and views of neurologists regarding the use of whole-genome sequencing in clinical settings: a web-based survey.European journal of human genetics : EJHG · 2017Article
- Incidental findings of uncertain significance: To know or not to know--that is not the question.BMC medical ethics · 2016Article
- Article
- Perspectives on genetic and genomic technologies in an academic medical center: the duke experience.Journal of personalized medicine · 2015Article
- Living laboratory: whole-genome sequencing as a learning healthcare enterprise.Clinical genetics · 2015Review
- Application of molecular profiling in clinical trials for advanced metastatic cancers.Journal of the National Cancer Institute · 2015Article
- To disclose, or not to disclose? Context matters.European journal of human genetics : EJHG · 2015Article
- Management and return of incidental genomic findings in clinical trials.The pharmacogenomics journal · 2015Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.